BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:329-339. [PMID: 23316916 DOI: 10.1517/13543784.2013.761205] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Weaver KR, Melkus GD, Fletcher J, Henderson WA. Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome. Biol Res Nurs 2018;20:312-20. [PMID: 29402137 DOI: 10.1177/1099800418756733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Chang FY. Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol. 2014;20:2499-2514. [PMID: 24627587 DOI: 10.3748/wjg.v20.i10.2499] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
3 Drossman DA. Treatment of Residual Inflammatory Bowel Disease Symptoms With Low-dose Tricyclic Antidepressants: Why Not? Journal of Clinical Gastroenterology 2014;48:390-2. [DOI: 10.1097/mcg.0000000000000098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG, Sidani S, Vanner S. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J Can Assoc Gastroenterol 2019;2:6-29. [PMID: 31294724 DOI: 10.1093/jcag/gwy071] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
5 Weaver KR, Sherwin LB, Walitt B, Melkus GD, Henderson WA. Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther 2016;7:320-33. [PMID: 27158548 DOI: 10.4292/wjgpt.v7.i2.320] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
6 Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil. 2014;26:1642-1650. [PMID: 25244442 DOI: 10.1111/nmo.12444] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
7 Corsetti M, Whorwell P. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline. Expert Rev Gastroenterol Hepatol 2017;11:285-92. [PMID: 28276811 DOI: 10.1080/17474124.2017.1298442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Liu G, Li S, Chen N, Zhao Z, Guo M, Liu H, Feng J, Zhang D, Yao Z, Hu B. Inter-hemispheric Functional Connections Are More Vulnerable to Attack Than Structural Connection in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2021;27:426-35. [PMID: 34210908 DOI: 10.5056/jnm20134] [Reference Citation Analysis]
9 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 2020;40:1593-678. [PMID: 32115745 DOI: 10.1002/med.21666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
11 Wang D, Zhang X, Zhang X, Huang Z, Song Y. Magnetic resonance imaging analysis of brain function in patients with irritable bowel syndrome. BMC Gastroenterol 2017;17:148. [PMID: 29216847 DOI: 10.1186/s12876-017-0673-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
12 Coss-Adame E, Rao SS. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep. 2014;16:379. [PMID: 24595616 DOI: 10.1007/s11894-014-0379-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
13 Li X, Qiu W, Da X, Hou Y, Ma Q, Wang T, Zhou X, Song M, Bian Q, Chen J. A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anat Rec 2020;303:2154-67. [DOI: 10.1002/ar.24388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
14 Johnson AC, Greenwood-Van Meerveld B. The Pharmacology of Visceral Pain. Adv Pharmacol 2016;75:273-301. [PMID: 26920016 DOI: 10.1016/bs.apha.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Al Omran Y, Aziz Q. The brain-gut axis in health and disease. Adv Exp Med Biol 2014;817:135-53. [PMID: 24997032 DOI: 10.1007/978-1-4939-0897-4_6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
16 Lan L, Chen YL, Zhang H, Jia BL, Chu YJ, Wang J, Tang SX, Xia GD. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety. World J Gastroenterol. 2014;20:11422-11428. [PMID: 25170231 DOI: 10.3748/wjg.v20.i32.11422] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Anastasi JK, Capili B, Chang M. Managing irritable bowel syndrome. Am J Nurs 2013;113:42-52; quiz 54, 53. [PMID: 23764698 DOI: 10.1097/01.NAJ.0000431911.65473.35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
18 Pae CU, Lee SJ, Han C, Patkar AA, Masand PS. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:565-572. [PMID: 23506326 DOI: 10.1517/13543784.2013.782392] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
19 Mikocka-Walus A, Ford AC, Drossman DA. Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:184-92. [PMID: 32071420 DOI: 10.1038/s41575-019-0259-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
20 Skonieczna-Żydecka K, Jakubczyk K, Maciejewska-Markiewicz D, Janda K, Kaźmierczak-Siedlecka K, Kaczmarczyk M, Łoniewski I, Marlicz W. Gut Biofactory-Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review. Nutrients 2020;12:E3369. [PMID: 33139656 DOI: 10.3390/nu12113369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
21 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126-14131. [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 79] [Article Influence: 15.8] [Reference Citation Analysis]
22 Sun Y, Tan Y, Song G, Chen JDZ. Effects and mechanisms of gastric electrical stimulation on visceral pain in a rodent model of gastric hyperalgesia secondary to chemically induced mucosal ulceration. Neurogastroenterol Motil 2014;26:176-86. [DOI: 10.1111/nmo.12248] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
23 Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016;S0016-5085:27144624. [PMID: 27144624 DOI: 10.1053/j.gastro.2016.02.027] [Cited by in Crossref: 173] [Cited by in F6Publishing: 86] [Article Influence: 34.6] [Reference Citation Analysis]
24 Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med. 2018;60:213-222. [PMID: 30257542 DOI: 10.23736/s0031-0808.18.03541-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
25 Jang SH, Ryu HS, Choi SC, Lee SY. Psychological factors influence the overlap syndrome in functional gastrointestinal disorders and their effect on quality of life among firefighters in South Korea. J Dig Dis 2016;17:236-43. [PMID: 26896638 DOI: 10.1111/1751-2980.12330] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Sharbafchi MR, Afshar H, Adhamian P, Feizi A, Daghaghzadeh H, Adibi P. Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome. J Res Med Sci 2020;25:115. [PMID: 33912225 DOI: 10.4103/jrms.JRMS_699_19] [Reference Citation Analysis]
27 Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 2018;15:168-80. [PMID: 29139482 DOI: 10.1038/nrgastro.2017.141] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
28 Sobin HW, Heinrich TW, Drossman DA. Central Neuromodulators for Treating Functional GI Disorders: A Primer. American Journal of Gastroenterology 2017;112:693-702. [DOI: 10.1038/ajg.2017.57] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
29 Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K, Whorwell PJ. Centrally Mediated Disorders of Gastrointestinal Pain. Gastroenterology 2016:S0016-5085(16)00225-0. [PMID: 27144628 DOI: 10.1053/j.gastro.2016.02.034] [Cited by in Crossref: 64] [Cited by in F6Publishing: 30] [Article Influence: 12.8] [Reference Citation Analysis]
30 Vázquez GH. The impact of psychopharmacology on contemporary clinical psychiatry. Can J Psychiatry 2014;59:412-6. [PMID: 25161065 DOI: 10.1177/070674371405900803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
31 Kurlander JE, Drossman DA. Diagnosis and treatment of narcotic bowel syndrome. Nat Rev Gastroenterol Hepatol 2014;11:410-8. [PMID: 24751914 DOI: 10.1038/nrgastro.2014.53] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
32 Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, Chen W, Wu D, Zhang F, Fang X. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2015;13:49. [PMID: 25925746 DOI: 10.1186/s12955-015-0243-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
33 Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110209. [PMID: 33326819 DOI: 10.1016/j.pnpbp.2020.110209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
34 Carmona-sánchez R, Icaza-chávez M, Bielsa-fernández M, Gómez-escudero O, Bosques-padilla F, Coss-adame E, Esquivel-ayanegui F, Flores-rendón Á, González-martínez M, Huerta-iga F, López-colombo A, Méndez-gutiérrez T, Noble-lugo A, Nogueira-de Rojas J, Raña-garibay R, Remes-troche J, Roesch-dietlen F, Schmulson M, Soto-pérez J, Tamayo J, Uscanga L, Valdovinos M, Valerio-ureña J, Zavala-solares M. Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 2016;81:149-67. [DOI: 10.1016/j.rgmx.2016.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Jing F, Zhang J. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders. Dig Dis Sci. 2014;59:2642-2648. [PMID: 24916714 DOI: 10.1007/s10620-014-3244-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
36 Tarantino S, Capuano A, Torriero R, Citti M, Vollono C, Gentile S, Vigevano F, Valeriani M. Migraine Equivalents as Part of Migraine Syndrome in Childhood. Pediatric Neurology 2014;51:645-9. [DOI: 10.1016/j.pediatrneurol.2014.07.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]